Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders.

MLA

Kleinboehl, Evan W., et al. “Engineering Memory T Cells as a Platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 32, no. 11, Nov. 2024, pp. 3865–78. EBSCOhost, https://doi.org/10.1016/j.ymthe.2024.09.033.

APA

Kleinboehl, E. W., Laoharawee, K., Jensen, J. D., Peterson, J. J., Slipek, N. J., Wick, B. J., Johnson, M. J., Webber, B. R., & Moriarity, B. S. (2024). Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders. Molecular Therapy : The Journal of the American Society of Gene Therapy, 32(11), 3865–3878. https://doi.org/10.1016/j.ymthe.2024.09.033

Chicago

Kleinboehl, Evan W, Kanut Laoharawee, Jacob D Jensen, Joseph J Peterson, Nicholas J Slipek, Bryce J Wick, Matthew J Johnson, Beau R Webber, and Branden S Moriarity. 2024. “Engineering Memory T Cells as a Platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders.” Molecular Therapy : The Journal of the American Society of Gene Therapy 32 (11): 3865–78. doi:10.1016/j.ymthe.2024.09.033.